M. Micksche

B. Ghanim, W. Berger, W. Klepetko, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Self-reported prostate cancer screening in Austria

P. Sevelda, M. Micksche, T. Waldhoer, 2006, Journal of medical screening.

Maximal androgen blockade in combination with methotrexate for treatment of metastatic prostate cancer

H. Ludwig, E. Fritz, M. Micksche, 2005, Journal of Cancer Research and Clinical Oncology.

Interferon-α-carboplatin combination therapy for metastatic melanoma: Phase II study

M. Micksche, A. Rehberger, E. Kokoschka, 1994 .

Treatment of advanced colorectal cancer with folinic acid and 5-fluorouracil in combination with cisplatinum.

H. Umek, M. Micksche, R. Essl, 1994, European journal of cancer.

Temozolomide for recurrent or progressive high-grade malignant glioma: Results of an Austrian multicenter observational study

J. Pichler, C. Marosi, F. Payer, 2006, Wiener klinische Wochenschrift.

Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.

T. Mohr, H. Pehamberger, J. Drach, 2009, Journal of proteome research.

[Results of a comparative therapy study for inoperable lung cancer].

C. Cerni, E. Ogris, M. Micksche, 1982, Onkologie.

No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.

A. Baierl, E. Feik, P. Hofer, 2011, Cancer epidemiology.

Association of IGF 1 and IGFBP 3 polymorphisms with colorectal polyps and colorectal cancer risk

A. Baierl, S. Stättner, E. Feik, 2009 .

Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk

A. Baierl, S. Stättner, E. Feik, 2009, Cancer Causes & Control.

Hydrogen peroxide mediates EGCG-induced antioxidant protection in human keratinocytes.

W. Berger, M. Grusch, C. Jantschitsch, 2010, Free radical biology & medicine.

Serum proteins and cytokines for prediction of sepsis?

F. Trautinger, M. Micksche, R. Kirnbauer, 1989, Progress in clinical and biological research.

Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer

M. Micksche, M. Vetterlein, G. Breitenecker, 1989 .

Common genetic polymorphisms of AURKA and prostate cancer risk

A. Baierl, R. Berges, E. Feik, 2009, Cancer Causes & Control.

Null Results in Brief A Polymorphism in the UDP-Glucuronosyltransferase 2 B 15 Gene ( D 85 Y ) Is Not Associated with Prostate Cancer Risk

M. Marberger, S. Madersbacher, A. Gsur, 2002 .

A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.

M. Marberger, S. Madersbacher, A. Gsur, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Green tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activities

W. Berger, R. Schulte‐Hermann, M. Micksche, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Prospective evaluation of interferon-α in treatment of chronic active Crohn's disease

W. Reinisch, H. Lochs, A. Gangl, 1995, Digestive Diseases and Sciences.

Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.

T. Luger, M. Micksche, J. Oppenheim, 1983, Journal of immunology.

Production of distinct cytokines by epidermal cells

T. Luger, M. Micksche, T. Luger, 1985, The British journal of dermatology.

Interferon-α Therapy in Dermatology

M. Micksche, 1997 .

MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer.

A. Baierl, E. Feik, P. Hofer, 2011, Carcinogenesis.

Modification of growth and tumorigenicity in epidermal cell lines by DNA-mediated gene transfer of M(r) 27,000 heat shock protein (hsp27).

F. Trautinger, C. Jantschitsch, M. Micksche, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[Vitronectin in bronchoalveolar lavage--a parameter of disease activity in sarcoidosis].

S. Rennard, H. Umek, M. Micksche, 1993, Wiener klinische Wochenschrift.

Randomised study using IFN-a versus IFN-a plus coumarin and cimetidine for treatment of advanced renal cell cancer

H. Ludwig, M. Micksche, J. Flamm, 1995 .

Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin.

W. Berger, M. Sulyok, P. Chiba, 2009, Molecular nutrition & food research.

Cytokines and human malignant melanoma. Immuno- and growth-regulatory peptides in melanoma biology.

M. Micksche, T. Luger, T. Schwarz, 1991, Cancer treatment and research.

MNS 16 A tandem repeats minisatellite of human telomerase gene : a risk factor for colorectal cancer

A. Baierl, E. Feik, P. Hofer, 2011 .

Influence of brachytherapy (192Ir afterloading) on cell-mediated immune reactions in patients with stage I endometrial cancer.

M. Micksche, S. Kudlacek, H. Kucera, 1989, Gynecologic oncology.

Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2

H. Pehamberger, M. Freissmuth, M. Micksche, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines.

I. Elmadfa, M. Micksche, A. Meyer, 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

A novel bioassay for P-glycoprotein functionality using cytochalasin D.

W. Berger, D. Printz, M. Micksche, 1998, Cytometry.

Interferon-α in the Treatment of Chronic Myeloproliferative Disorders with Thrombocytosis

M. Micksche, C. Schmid, H. Seewann, 1990 .

Abstract

K. Laczika, C. Marosi, D. Fuchs, 1984, Veterinary Record.

Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system

W. Berger, F. Trautinger, A. Gsur, 2003, Cell stress & chaperones.

Overexpression of Hsp25 in K1735 murine melanoma cells enhances susceptibility to natural killer cytotoxicity

G. Klosner, F. Trautinger, A. Gsur, 2002, Cell stress & chaperones.

IFN-beta 2/IL-6 augments the activity of human natural killer cells.

T. Luger, J. Krutmann, M. Micksche, 1989, Journal of immunology.

Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions

A. Uchida, M. Micksche, Michael Micksche, 1983, International journal of cancer.

Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

W. Berger, T. Szekeres, M. Jakupec, 2009, Current cancer drug targets.

Complementary therapies in cancer patients: prevalence and patients’ motives

M. Micksche, C. Vutuc, T. Zidek, 2003, Wiener Klinische Wochenschrift.

Suppressor cells for natural killer activity in carcinomatous pleural effusions of cancer patients

A. Uchida, M. Micksche, 1981, Cancer Immunology, Immunotherapy.

Concanavalin A-inducible suppressor cells in pleural effusions and peripheral blood of cancer patients

A. Uchida, M. Micksche, 1981, Cancer Immunology, Immunotherapy.

Autologous mixed lymphocyte reaction in the peripheral blood and pleural effusions of cancer patients.

A. Uchida, M. Micksche, 1982, The Journal of clinical investigation.

Expression of the multidrug resistance‐associated protein (MRP) and chemoresistance of human non‐small‐cell lung cancer cells

W. Berger, M. Micksche, L. Elbling, 1997, International journal of cancer.

Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.

M. Remzi, M. Marberger, A. Gsur, 2005, Urology.

Effect of granulocyte-macrophage colony-stimulating factor on natural-killer cell mediated cytotoxicity.

K. Trieb, M. Micksche, B. Kubista, 2003, The international journal of biochemistry & cell biology.

Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients

A. Uchida, M. Micksche, M. Moore, 2004, Cancer Immunology, Immunotherapy.

Granulocytes of critically ill patients spontaneously express the 72 kD heat shock protein.

F. Trautinger, M. Micksche, C. Oismüller, 1993, Circulatory shock.

Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.

K. Trieb, S. Madersbacher, A. Gsur, 2001, Anticancer research.

Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region.

M. Micksche, K. Vinzenz, 1987, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432

A. Uchida, M. Micksche, E. Yanagawa, 2004, Cancer Immunology, Immunotherapy.

Preoperative Local Immunotherapy with OK-432 (Picibanil) in Patients with Squamous Cell Cancer of the Oral Cavity

G. Watzek, M. Micksche, M. Matejka, 1990 .

Natural killer cells in carcinomatous pleural effusions

A. Uchida, M. Micksche, 1981, Cancer Immunology, Immunotherapy.

In vitro augmentation of natural killing activity by OK-432.

A. Uchida, M. Micksche, 1981, International journal of immunopharmacology.

Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients

A. Uchida, M. Micksche, E. Kokoschka, 2004, Cancer Immunology, Immunotherapy.

Proteolytic Enzymes in the Treatment of Malignant Pleural Effusions and Solid Metastases

C. Cerni, M. Micksche, H. Wrba, 1976 .

Respiratory Burst Capability of Polymorphonuclear Neutrophils and TNF‐α Serum Levels in Relationship to the Development of Septic Syndrome in Critically III Patients

F. Trautinger, M. Micksche, A. Hammerle, 1991, Journal of leukocyte biology.

Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).

Petra Heffeter, Walter Berger, W. Berger, 2006, Biochemical pharmacology.

Oxidative stress and DNA interactions are not involved in Enniatin- and Beauvericin-mediated apoptosis induction.

Doris Marko, Petra Heffeter, Walter Berger, 2009, Molecular nutrition & food research.

Resistance against novel anticancer metal compounds: differences and similarities.

W. Berger, M. Jakupec, M. Galanski, 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity

W. Berger, M. Grusch, M. Micksche, 2008, Cellular and Molecular Life Sciences.

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).

C. Pirker, W. Berger, P. Chiba, 2007, Biochemical pharmacology.

Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids.

F. Trautinger, R. Knobler, M. Micksche, 1991, Journal of the American Academy of Dermatology.

Whole genome amplification for CGH analysis: Linker‐adapter PCR as the method of choice for difficult and limited samples

S. Spiegl-Kreinecker, C. Pirker, W. Berger, 2004, Cytometry Part A.

Stimulation of immune response in lung cancer patients by vitamin A therapy.

C. Cerni, M. Micksche, H. Wrba, 1977, Oncology.

The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma

I. Witz, M. Micksche, I. Yron, 2002, Oncogene.

Possible role of the multidrug resistance‐associated protein (MRP) in chemoresistance of human melanoma cells

W. Berger, M. Micksche, L. Elbling, 1997, International journal of cancer.

Expression and release of interleukin-1 by different human melanoma cell lines.

H. Kung, T. Luger, H. Kung, 1989, Journal of the National Cancer Institute.

Adjuvant Immunotherapy of Stage II Malignant Melanoma: Autologous Tumor Antigen Plus BCG

M. Micksche, E. Kokoschka, 1979 .

Influence of thia-benzimidazole Wy 18251 of cancer patients' lymphocyte reactivity.

M. Micksche, M. Colot, 1982, Journal of immunopharmacology.

Response of experimental malignant melanoma models to the pan‐Aurora kinase inhibitor VE‐465

S. Spiegl-Kreinecker, D. Lötsch, C. Pirker, 2010, Experimental dermatology.

Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes

S. Spiegl-Kreinecker, W. Berger, G. Wurm, 2002, Journal of Neuro-Oncology.

Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes

S. Spiegl-Kreinecker, C. Pirker, W. Berger, 2003, Melanoma research.

Chemoresistance of Human Malignant Melanoma: Cellular and Molecular Aspects

W. Berger, M. Micksche, L. Elbling, 1998, Oncology Research and Treatment.

Expression of the multidrug resistance‐associated protein (MRP) and chemoresistance of human non‐small‐cell lung cancer cells

W. Berger, M. Micksche, L. Elbling, 1997 .

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

W. Berger, B. Keppler, W. Körner, 2010, JBIC Journal of Biological Inorganic Chemistry.

Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes

A. Uchida, M. Micksche, T. Hoshino, 2004, Cancer Immunology, Immunotherapy.

An improved antigenic marker of human lung carcinomas and its use in radioimmunoassays.

M. Micksche, H. Bauer, A. Wolf, 1981, British Journal of Cancer.

Systemic treatment of extensive condylomata acuminata with interferon alfa-2b.

M. Micksche, D. Grablowitz, J. Söltz-Szöts, 1992, Journal of the American Academy of Dermatology.

Enhanced PHA stimulation of cancer patients' lymphocytes by addition of BM 12531 (azimexon) in vitro

M. Micksche, U. Bicker, M. Colot, 1979, Cancer Immunology, Immunotherapy.

Multiple chromosomal abnormalities in human liver (pre)neoplasia.

C. Pirker, W. Berger, R. Schulte‐Hermann, 2004, Journal of hepatology.

Overexpression of the human major vault protein in astrocytic brain tumor cells

Walter Berger, S. Spiegl-Kreinecker, C. Pirker, 2001, International journal of cancer.

A small upstream open reading frame causes inhibition of human major vault protein expression from a ubiquitous mRNA splice variant

W. Berger, M. Micksche, L. Elbling, 2001, FEBS letters.

Down-Regulation of Sprouty2 in Non–Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms

W. Berger, J. Attems, W. Mikulits, 2007, Molecular Cancer Research.

O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.

S. Spiegl-Kreinecker, D. Lötsch, C. Pirker, 2010, Neuro-oncology.

Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk

A. Baierl, P. Hofer, A. Gsur, 2012, Molecular carcinogenesis.

Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

H. Bergmeister, C. Pirker, W. Berger, 2006, Cancer research.

Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders

A. Chott, H. Gisslinger, H. Ludwig, 2004, Cancer Immunology, Immunotherapy.

Mechanisms underlying the anticancer activities of the angucycline landomycin E.

W. Berger, R. Stoika, P. Heffeter, 2007, Biochemical pharmacology.

Natural killer cell activity in mouse aggregation chimeras.

M. Micksche, L. Elbling, G. Sauermann, 1981, Cellular immunology.

The role of macrophages in antitumor defense of patients with ovarian cancer.

C. Verschraegen, A. Loercher, R. Freedman, 1999, Hematology/oncology clinics of North America.

Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.

S. Spiegl-Kreinecker, C. Pirker, W. Berger, 2011, The Journal of investigative dermatology.

Association of polymorphisms within androgen receptor, 5α‐reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men

M. Marberger, A. Haitel, S. Madersbacher, 2002, The Prostate.

Impact of radiotherapy with and without concurrent cisplatin on lymphocyte subpopulations in cervical cancer patients.

J. Dimopoulos, R. Poetter, M. Micksche, 2005, Anticancer research.

Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk

K Trieb, C Vutuc, K Schnattinger, 2003, British Journal of Cancer.

IN VIVO MODULATION OF HUMAN NEUTROPHIL FUNCTION BY PENTOXIFYLLINE IN PATIENTS WITH SEPTIC SYNDROME

M. Micksche, N. Mayer, H. Steltzer, 1995, Shock.

SUPPRESSION OF NK CELL ACTIVITY BY ADHERENT CELLS FROM MALIGNANT PLEURAL EFFUSIONS OF CANCER PATIENTS

A. Uchida, M. Micksche, 1982 .

Correlation of immune response with clinical stage in Lewis lung tumor-bearing mice.

M. Micksche, T. Kurata, 1978, Oncology.

Reactivity to autologous non-T-cells and suppressor function of human autologous rosettes.

A. Uchida, M. Micksche, 1981, Immunology letters.

The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals

C. Pirker, W. Berger, H. Sutterlüty, 2006, Journal of Cell Science.

[Recommendations on cancer screening in the European Union].

T. Davies, U. Veronesi, J. Faivre, 2001, Bulletin du cancer.

Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.

M. Marberger, S. Madersbacher, A. Gsur, 2002, Carcinogenesis.

Vitamin D receptor gene polymorphism and prostate cancer risk

M. Marberger, S. Madersbacher, A. Gsur, 2002, The Prostate.

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

W. Berger, B. Grasl-Kraupp, M. Grusch, 2008, Molecular Cancer Therapeutics.

epidermal growth factor receptor inhibition cancer cells : therapeutic implications and synergism with contribute to the malignant phenotype of non-small cell lung Fibroblast growth factor receptor-mediated signals

W. Berger, B. Grasl-Kraupp, M. Grusch, 2008 .

Long-Term Adjuvant Therapy of High-Risk Malignant Melanoma with Interferon α2b

F. Trautinger, R. Knobler, M. Micksche, 1990 .

Aspects of the immunologic treatment of lung cancer.

E. Ogris, M. Micksche, G. Alth, 1973, Cancer chemotherapy reports. Part 3.

Therapeutic effect of cryosurgery of murine osteosarcoma--influence on disease outcome and immune function.

F. Kerschbaumer, M. Micksche, S. Yamagata, 1985, Cryobiology.

In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.

A. Uchida, H. Koren, M. Micksche, 1984, British Journal of Cancer.

Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.

A. Uchida, M. Micksche, E. Maida, 1982, Immunobiology.

New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis

C. Pirker, T. Mohr, W. Berger, 2008, British Journal of Cancer.

Interferon alpha‐2 for hairy cell leukemia: Evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells

T. Lion, L. Wagner, M. Micksche, 1987, European journal of haematology.

Treatment with biologic response modifiers in patients with ovarian cancer.

M. Micksche, G. Gitsch, H. Koelbl, 1991, European journal of obstetrics, gynecology, and reproductive biology.

Systemic and regional natural cytotoxicity in patients with head and neck cancer.

M. Micksche, K. Vinzenz, 1986, Journal of maxillofacial surgery.

Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.

A. Uchida, M. Micksche, M. Colot, 1984, British Journal of Cancer.

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.

A. Uchida, M. Micksche, 1983, Journal of the National Cancer Institute.

Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma

S. Spiegl-Kreinecker, C. Pirker, J. Pichler, 2007, British Journal of Cancer.

Plasmapheresis in patients with advanced malignant disease: a pilot study.

M. Micksche, E. Kokoschka, H. Rainer, 1982, Oncology.

Serum lysozyme levels in patients with solid tumors.

T. Luger, M. Micksche, E. Kokoschka, 1979, Oncology.

AUGMENTATION OF HUMAN NATURAL KILLING ACTIVITY BY OK432

A. Uchida, M. Micksche, 1982 .

In vitro cell culture systems as the basis for an extracorporeal blood purification strategy in multiorgan failure treatment.

D. Falkenhagen, E. Rossmanith, M. Micksche, 1999, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Plasmapheresis for Therapy in Patients with Metastasizing Solid Tumors

M. Micksche, E. Kokoschka, H. Rainer, 1981 .

Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement.

M. Marberger, A. Haitel, S. Madersbacher, 2001, Urology.

Daily Intake of Probiotic as well as Conventional Yogurt Has a Stimulating Effect on Cellular Immunity in Young Healthy Women

I. Elmadfa, M. Micksche, A. Meyer, 2006, Annals of Nutrition and Metabolism.

Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure

M. Schemper, C. Dittrich, M. Micksche, 1986 .

Effect of adjuvant chemo‐ or immunotherapy on the prognosis of colorectal cancer operated for cure

M. Schemper, C. Dittrich, M. Micksche, 1985, The British journal of surgery.

Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality

S. Madersbacher, M. Micksche, T. Waldhoer, 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Anticancer effects of zoledronic acid against human osteosarcoma cells

W. Berger, H. Sutterlüty, K. Scotlandi, 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Self-Reported Opportunistic Screening Mammography in Austria – 2005 vs. 1995

P. Sevelda, M. Micksche, T. Waldhoer, 2007, Breast Care.

Cellular functions of vaults and their involvement in multidrug resistance.

W. Berger, M. Micksche, L. Elbling, 2006, Current drug targets.

CHARACTERIZATION OF PROTEINS ASSOCIATED WITH HEAT SHOCK PROTEIN HSP27 IN THE SQUAMOUS CELL CARCINOMA CELL LINE A431

F. Trautinger, M. Micksche, I. Kindås-mügge, 2002, Cell biology international.

Pharmacokinetic aspects of interferon alfa-2b after intrahepatic or intraperitoneal administration.

W. Jäger, M. Czejka, M. Micksche, 1992, Seminars in oncology.

Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease.

W. Reinisch, H. Lochs, A. Gangl, 1995, Digestive diseases and sciences.

Long-term adjuvant therapy of high-risk malignant melanoma with interferon alpha 2b.

F. Trautinger, R. Knobler, M. Micksche, 1990, The Journal of investigative dermatology.

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance

D. Lötsch, C. Pirker, W. Berger, 2015, Journal of experimental & clinical cancer research : CR.

Breaking bad news to cancer patients: survey and analysis

H. Karlic, M. Micksche, C. Vutuc, 2009, Psycho-oncology.

Genetic polymorphisms of cytochrome P4501A1 and glutathione S-transferase M1: a lung cancer case control study

K. Trieb, S. Madersbacher, A. Gsur, 1999 .

Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma.

H. Ludwig, M. Micksche, E. Kokoschka, 1985, Oncology.

Cancer patients' perception of information exchange between hospital-based doctors and their general practitioners.

H. Karlic, M. Micksche, C. Vutuc, 2010, Journal of evaluation in clinical practice.

P‐Glycoprotein regulates chemosensitivity in early developmental stages of the mouse

W. Berger, T. Waldhör, M. Micksche, 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.

T. Luger, A. Uchida, M. Micksche, 1985, Journal of immunology.

Antitumor activity of imexon.

M. Micksche, E. Kokoschka, P. Sagaster, 1995, Journal of the National Cancer Institute.

Intrinsic MDR‐1 gene and P‐glycoprotein expression in human melanoma cell lines

W. Berger, R. Pirker, M. Micksche, 1994, International journal of cancer.

Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.

M. Micksche, O. Kokron, 1977, Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology.

IN VIVO MODULATION OF HUMAN NEUTROPHIL FUNCTION BY PENTOXIFYLLIN IN SEPTIC PATIENTS

M. Micksche, N. Mayer, C. Oismüller, 1991 .

Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.

G. Watzek, M. Micksche, M. Matejka, 1987, Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc.

The burden of cancer in Austria.

M. Micksche, T. Waldhoer, G. Haidinger, 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: interim results.

F. Cavalli, H. Senn, H. Ludwig, 1991, European journal of cancer.

ALVEOLAR MACROPHAGES OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME EXPRESS HIGH LEVELS OF HEAT SHOCK PROTEIN 72 mRNA

M. Micksche, E. Zavadova, W. Pohl, 1996, Shock.

Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.

C. Cerni, M. Micksche, 1975, Acta neuropathologica. Supplementum.

Effectiveness of postoperative adjuvant therapy with cytotoxic chemotherapy (cytosine arabinoside, mitomycin C, 5-fluorouracil) or immunotherapy (neuraminidase-modified allogeneic cells) in the prevention of recurrence of Duke's B and C colon cancer.

M. Schemper, M. Micksche, R. Schiessel, 1981, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.